Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 206

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 206
---
 |     | Stock                                                   
 Awards                                                  
 Number of shares or units of stock that have not vested 
 (#)                                                     |   |     | Market value of shares or units of stock that have not vested 
 ($)                                                           |   |
|:------------------------------------------------------------|:----|:---------------------------------------------------------------------|------:|:----|:----------------------------------------------------------------------|:--|:----|:--------------------------------------------------------------------------|-------:|:----|:----------------------|------:|:----|:-------------------|:----|:--------------------------------------------------------|:--|:----|:--------------------------------------------------------------|:--|
| Geoffrey Dow, President and Chief Executive                 
 Officer (Principal Executive Officer)(1)                    |     |                                                                      | 5,000 |     |                                                                       | - |     |                                                                           | 20,000 |     | $                     | 12.00 |     | July 16, 2034      |     |                                                         | - |     | $                                                             | - |
| Tyrone Miller, Chief Financial Officer (Principal Financial 
 and Accounting Officer)(2)                                  |     |                                                                      | 4,000 |     |                                                                       | - |     |                                                                           | 16,000 |     | $                     | 12.00 |     | July 16, 2034      |     |                                                         | - |     | $                                                             | - |
| Kristen Landon, Chief Commercial Officer(3)                 |     |                                                                      | 4,167 |     |                                                                       | - |     |                                                                           | 16,667 |     | $                     |  1.37 |     | September 26, 2034 |     |                                                         | - |     | $                                                             | - |

| (1) | Dr. Dow’s options to purchase a total of 25,000 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December 31, 2024. |

| (2) | Mr. Miller’s options to purchase a total of 20,000 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December 31, 2024. |

| (3) | Ms. Landon’s options to purchase a total of 20,834 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December 31, 2024.